Brainsway (BWAY) has released an update.
BrainsWay Ltd. has announced the expansion of its Deep TMS treatment in Israel, driven by a recent 45% increase in reimbursement rates and the installation of 11 new systems, with more expected by the end of 2024. The company aims to provide its noninvasive neurostimulation treatments to a growing number of mental health patients, responding to the rising need for alternative therapies in the country.
For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.
